The UK Biobank resource with deep phenotyping and genomic data
By Clare Bycroft, C. Freeman, Desislava Petkova, G. Band, L. Elliott, Kevin Sharp, A. Motyer, Damjan Vukcevic, Olivier Delaneau, Jared O’Connell and 9 more. 2018
7,745 citations recorded by the source corpus.
The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment. The open resource is unique in its size and scope. A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain. Follow-up information is provided by linking health and medical records. Genome-wide genotype data have been collected on all participants, providing many opportunities for the discovery of new genetic associations and the genetic bases of complex traits. Here we describe the centralized analysis of the genetic data, including genotype quality, properties of population structure and relatedness of the genetic data, and efficient phasing and genotype imputation that increases the number of testable variants to around 96 million. Classical allelic variation at 11 human leukocyte antigen genes was imputed, resulting in the recovery of signals with known associations between human leukocyte antigen alleles and many diseases. Deep phenotype and genome-wide genetic data from 500,000 individuals from the UK Biobank, describing population structure and relatedness in the cohort, and imputation to increase the number of testable variants to 96 million.
Subfields: Cancer Research, Genetics, Molecular Biology, Computational Biology & Bioinformatics
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
- Alkes L Price
- Matthew Stephens
- Sharon R. Browning
- Jonathan Marchini
- Brian L. Browning
- Gonçalo R. Abecasis
- Peter M. Visscher
- Naomi R. Wray
In Molecular Biology
- Alkes L Price
- Jonathan Marchini
- Sharon R. Browning
- Gonçalo R. Abecasis
- D. McCloskey
- Brian L. Browning
- Cristen J. Willer
- Peter L. Ralph
In Computational Biology & Bioinformatics
- Michael E. Goddard
- Peter M. Visscher
- Matthew Stephens
- Naomi R. Wray
- Alexander Rives
- Pushmeet Kohli
- Eric J. Topol
- Charles L. Kooperberg
Citations in the corpus
- Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences (2019, background): “The mutational fitness landscape provides deep insight into biology: determining protein activity (Fowler & Fields, 2014), linking genetic variation to human health (Lek et al., 2016; Bycroft et al., 2018; Karczewski et al., 2019), and enabling for rational protein engineering (Slaymaker et al.”
- Computationally efficient whole-genome regression for quantitative and binary traits (2020, methodology): “This is similar to the approach implemented in the BGENIE software for single SNP linear regression analysis 17 .”
- Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program (2019, methodology): “Then, we tested for lower/higher average L and S in a GO term using bootstrapping (1,000,000 samples) with adjustment for protein-coding gene length (CDS): (1) sort all genes by their CDS length in ascending order and divide them into equal-size bins (1,000 genes each); (2) count how many genes f”
- Brain age prediction using deep learning uncovers associated sequence variants (2019, methodology): “Roughly 10% of the subjects were genotyped using applied Biosystems UK BiLEVE Axiom Array by Affymetrix and the rest using the closely related Applied Biosystems UK Biobank Axiom Array 77 .”
- A foundation model for generalizable disease detection from retinal images (2023, methodology): “The final category of tasks studies the 3-year prediction of systemic diseases, with a focus on cardiovascular and neurodegenerative dysfunctions, using the MEH-AlzEye and UK Biobank.”
- Improved polygenic prediction by Bayesian multiple regression on summary statistics (2019, methodology): “Genotype data were imputed to the Haplotype Reference Consortium and UK10K panel, which was provided as part of the data release and described in Bycroft et al. 49 , and contained SNPs, short indels and large structural variants.”
- Functionally-informed fine-mapping and polygenic localization of complex trait heritability (2019, methodology): “We evaluated PolyFun via simulations using real genotypes from 337,491 unrelated UK Biobank British samples 27 .”
- Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis (2020, neutral): “Further details on genotyping quality control, phasing, imputation, and association testing have been reported previously [36,37].”